AIDS PATHOPHYSIOLOGY. pptx

CASE STUDY ON
PULMONARY TUBERCULOSIS
PREPARED BY :
D.LOGESHTHARAN
PHARM.D 2ND YEAR
(VISTAS)
PATIENT DEMOGRAPHIC
DETAILS
• Patient Name : Mr. X
• Age : 56 Years
• Gender : Male
• Date Of Admission : 14/01/2022
• Date Of Discharge : 19/01/2022
• Depart : Chest & TB
CHIEF COMPLAINTS
A 56 Years Old Male Patient Came To The Hospital With The
Complaints Of
 Cough with Expectoration Which is Whitish in Color Since 2 Months
Tiredness
HISTORY OF PRESENT
ILLNESS
Patient was apparently normal 2 months ago when he
developed cough with expectoration which is whitish in color which is
not foul smelling.
 H/O fatigue, lethargy, weight loss of about 6 Kg and fever.
PAST MEDICAL HISTORY : NIL
PAST MEDICATION HISTORY : NIL
PERSONAL HISTORY / SOCIAL HABITS
Normal bowel and bladder habits
SMOKER : YES
ALCOHOLIC : YES
OBJECTIVE EVIDENCE
• The Patient Is Conscious
• Febrile
• Temp : 100
• Pulse : 78 Beats/Min
• BP : 120/80mm Hg
• CVS :S1s2+ve
• RS : Crepts
• CNS : NFND
• P/A : Soft
PHYSICAL EXAMINATION SYSTEM EXAMINATION
LABORATORY
INVESTIGATIONS
PARAMETER OBSERVED VALUE NORMAL VALUE
HAEMOGLOBIN 13.5g / dl 14 – 18 g/dl
TC 39000/mm³ 32000-98000/mm³
ESR 40 mm in 1st hour 0-30 mm in 1st hour
PACKED CELL
VOLUME ( PCV)
39.3% 33-43 %
MCV 79 µm³ 76-100ͯµm³
RBC 4.9 millions/cu mm 3.6 – 5 millions/cu mm
TOTAL WBC 6,400 cells/cu mm 4500 – 11000 per µl
PLATELET COUNT 3.02 l/cmm 1.4 – 4.5 l/cmm
BICARBONATE 27mmol/L Below 3.0mg/dl
ELECTROLYTE PROFILE
LABORATORY
INVESTIGATIONS
PARAMETER OBSERVED VALUE NORMAL VALUE
LIVER
Bili (T) 0.9 mg/dl (< 1.0)
Bili (D) 0.2 mg/dl (< 0.2)
Bili (ID) 0.2 mg/dl (< 0.8)
SGPT 9 U/L (Upto 35)
SGOT 17 U/L (Upto 40)
T.Protein 7.19 g% (6.0 – 8.0)
Alk. Phosphatase 115 U/L (40 – 130)
Albumin 3.7 g% (3.2 – 4.5)
Glubulin 3.4 g% (2.3 – 3.5)
OTHER TESTS :
• Chest XRAY
• Sputum AFB
IMPRESSION :
• Chest XRAY – Significant Cavites Found
• Sputum AFB : A+ , B+
DIAGNOSIS :
• PULMONARY TUBERCULOSIS
ASSESSMENT
• From The Subjective And Objective Evidence The
Patient Is Assessed To Have
PULMONARY TUBERCULOSIS
TREATMENT
S.N
O
BRAND NAME GENERIC
NAME
DOSE FREQUENCY 1D 2D 3D
1 Inj.Ceftrioxone Ciprofloxacin 500 mg 1-0-1   
2 Inj.Amikacin Amikin 250 mg 1-1-1   
3 T.Para Sulfasalazine 500 mg 1-1-1   
4 T.AKT 4 Isoniazid,
Riampicin ,
Pyrazenamid
2I,R1
Z,E
1-0-1   
DRUGS ON DISCHARGE
S.N
O
BRAND NAME GENERIC
NAME
DOSE FREQUENCY 1D 2D 3D
1 Inj.Ceftrioxone Ciprofloxacin 500 mg 1-0-1   
2 Inj.Amikacin Amikin 250 mg 1-1-1   
3 T.Para Sulfasalazine 500 mg 1-1-1   
4 T.AKT 4 Isoniazid,
Riampicin ,
Pyrazenamid
2I,R1
Z,E
1-0-1   
DRUG INTERACTION :
Amikacin can sometimes cause kidney damage, and using
it with a cephalosporin antibiotic like ceftriaxone may
increase that risk.
Signs and symptoms of kidney damage may include
nausea , vomiting, loss of appetite, increased or decreased
urination, sudden weight gain or weight loss, fluid retention,
swelling, shortness of breath, muscle cramps, tiredness,
weakness, dizziness, confusion, and irregular heart rhythm.
cefTRIAXone = amikacin
Applies to: ceftriaxone, Amikin (amikacin)
PHARMACIST INTERVENTION
SUBJECTIVE
A 56 years old male patient was admitted in the
hospital with c/o cough with expectoration
which is whitish in color since2 months
H/O fatigue, lethargy, weight loss of
about 6 kg and fever.
Personal history: He is a smoker and alcoholic.
OBJECTIVE
Systemic and physical examination was found to be
normal SGPT and GOT were found to be Decreased.
Chest X ray: Significant cavities found
Sputum AFB: A+ B+
ASSESSMENT PULMONARY TUBERCULOSIS
PLAN OF TREATMENT
Patient was given treatment with T.Para
Inj.Ceftrioxone, T.AKT 4,Inj. Amikacin.
SOAP NOTES
 T.Para (Paracetamol):
It is an analgesic and antipyretic drug used to relieve from fever
andpain. Take one tablet whenever required
 Inj.Ceftrioxone:
It is an antibiotic used to treat any infections. It is given twice daily.
 T.AKT 4:(Isoniazid + Rifampicin + Pyrazenamide):
These drugs are given to treat active tuberculosis infection. Take
2tablet of each thrice weekly
 Inj. Amikacin:
It is an antibiotic. This injection is given twice in a week
PATIENT COUNSELLING
• REGARDING DISEASE CONDITION:
 Cover your mouth and nose with a tissue.
 Put your used tissue in a closed bag and throw it away.
 If you don't have a tissue, cough or sneeze into your upper
sleeve or elbow, not your hands.
 Wash your hands often with soap and warm water for 20
seconds.
• REGARDING DRUGS:
Avoid Dairy Products Such As Milk,cheese,ice Cream
While Taking INJ.AMIKACIN
TO FACILITATE DRUG ABSORPTION IN THE EMPTY
STOMACH, YOU ARE ADVISED NOT TO TAKE FOOD FOR 2
HOURS BEFORE AND AFTER TAKING DRUGS.
Quit Alcohol When Taking Medications
• REGARDING THERAPEUTIC LIFESTYLE MODIFICATIONS:
As a TB patient, you must avoid caffeine, refined sugar
and flour, sodium, and bottled sauces.
 Foods containing saturated and trans fats worsen the TB
symptoms of diarrhoea and abdominal cramping and fatigue.
 Additionally, alcohol and tobacco are a definite no-no
during the disease treatment and cure phase
THANK YOU
1 de 19

Recomendados

Clinical case discussion on organophosphorus poisoning por
 Clinical case discussion on organophosphorus poisoning Clinical case discussion on organophosphorus poisoning
Clinical case discussion on organophosphorus poisoningDr Nikita Ingale
1.3K vistas51 diapositivas
Approach to Bullous lung disease por
Approach to Bullous lung diseaseApproach to Bullous lung disease
Approach to Bullous lung diseaseAbhishek Tandon
1.8K vistas34 diapositivas
case study on Tuberculosis por
case study on Tuberculosis case study on Tuberculosis
case study on Tuberculosis sandhoshini
7.5K vistas12 diapositivas
Acute exacerbation of COPD por
Acute exacerbation of COPDAcute exacerbation of COPD
Acute exacerbation of COPDThomas Kurian
14.5K vistas66 diapositivas
Community acquired pneumonia por
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumoniaSaba Khan
5.2K vistas25 diapositivas
Sepsis and septic shock por
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shockmadhushah6
446 vistas50 diapositivas

Más contenido relacionado

La actualidad más candente

Case on bronchial asthma por
Case on bronchial asthmaCase on bronchial asthma
Case on bronchial asthmaAnusha Rameshwaram
1.1K vistas25 diapositivas
HIV and Pneumocystic jirovecii por
HIV and Pneumocystic jiroveciiHIV and Pneumocystic jirovecii
HIV and Pneumocystic jiroveciiAnkur Sharma
504 vistas20 diapositivas
An Interesting Case Of Hemoptysis por
An Interesting Case Of HemoptysisAn Interesting Case Of Hemoptysis
An Interesting Case Of HemoptysisStanley Medical College, Department of Medicine
2.5K vistas43 diapositivas
Hyperglycaemic Hyperosmolar State - Case Presentation por
Hyperglycaemic Hyperosmolar State - Case PresentationHyperglycaemic Hyperosmolar State - Case Presentation
Hyperglycaemic Hyperosmolar State - Case PresentationPraveen RK
1.3K vistas29 diapositivas
BRONCHIECTASIS por
BRONCHIECTASISBRONCHIECTASIS
BRONCHIECTASIS32KISHOREKUMAR
2.6K vistas46 diapositivas
Myocardial infraction by satyavardhan pharm.d por
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dSatya satyanittu4
8.2K vistas22 diapositivas

La actualidad más candente(20)

HIV and Pneumocystic jirovecii por Ankur Sharma
HIV and Pneumocystic jiroveciiHIV and Pneumocystic jirovecii
HIV and Pneumocystic jirovecii
Ankur Sharma504 vistas
Hyperglycaemic Hyperosmolar State - Case Presentation por Praveen RK
Hyperglycaemic Hyperosmolar State - Case PresentationHyperglycaemic Hyperosmolar State - Case Presentation
Hyperglycaemic Hyperosmolar State - Case Presentation
Praveen RK1.3K vistas
Myocardial infraction by satyavardhan pharm.d por Satya satyanittu4
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
Satya satyanittu48.2K vistas
Pneumonia - Classification & Etiology por Usman Shams
Pneumonia - Classification & EtiologyPneumonia - Classification & Etiology
Pneumonia - Classification & Etiology
Usman Shams3.3K vistas
PHYCOMYCOSIS.pptx por Doctorks
PHYCOMYCOSIS.pptxPHYCOMYCOSIS.pptx
PHYCOMYCOSIS.pptx
Doctorks309 vistas
CASE PRESENTATION ON TUBERCULOSIS por ashimajoseph123
CASE PRESENTATION ON TUBERCULOSISCASE PRESENTATION ON TUBERCULOSIS
CASE PRESENTATION ON TUBERCULOSIS
ashimajoseph1233.7K vistas
Aspiration Pneumonia Case presentation por Walaa Fahad
Aspiration Pneumonia Case presentationAspiration Pneumonia Case presentation
Aspiration Pneumonia Case presentation
Walaa Fahad8.9K vistas
Suppurative lung disease.ppt por Doti Guyo
Suppurative lung disease.pptSuppurative lung disease.ppt
Suppurative lung disease.ppt
Doti Guyo677 vistas
Case Presentation Dengue Fever por Zain Khan
Case Presentation Dengue FeverCase Presentation Dengue Fever
Case Presentation Dengue Fever
Zain Khan73.7K vistas

Similar a AIDS PATHOPHYSIOLOGY. pptx

A case study on tuberculosis por
A case study on tuberculosisA case study on tuberculosis
A case study on tuberculosisDrMaheshGurajapu
20.9K vistas12 diapositivas
Disseminated tuberculosis ppt1 por
Disseminated tuberculosis ppt1Disseminated tuberculosis ppt1
Disseminated tuberculosis ppt1BhuvanaDarawadi
356 vistas19 diapositivas
Case Presentation on Pneumonia por
Case Presentation on PneumoniaCase Presentation on Pneumonia
Case Presentation on PneumoniaChathreian S R
188 vistas27 diapositivas
CASE PRESENTATION ON ACUTE INFECTIOUS HEPATITIS por
CASE PRESENTATION ON ACUTE INFECTIOUS HEPATITISCASE PRESENTATION ON ACUTE INFECTIOUS HEPATITIS
CASE PRESENTATION ON ACUTE INFECTIOUS HEPATITISDR. METI.BHARATH KUMAR
1.9K vistas18 diapositivas
endometrial TB and erosive gastritis por
endometrial TB and erosive gastritisendometrial TB and erosive gastritis
endometrial TB and erosive gastritisAnusha Rameshwaram
129 vistas24 diapositivas
Case presentation on typhoid por
Case presentation on typhoidCase presentation on typhoid
Case presentation on typhoidLogeshwary M
34.8K vistas15 diapositivas

Similar a AIDS PATHOPHYSIOLOGY. pptx(20)

Case Presentation on Pneumonia por Chathreian S R
Case Presentation on PneumoniaCase Presentation on Pneumonia
Case Presentation on Pneumonia
Chathreian S R188 vistas
Case presentation on typhoid por Logeshwary M
Case presentation on typhoidCase presentation on typhoid
Case presentation on typhoid
Logeshwary M34.8K vistas
Migraine case Presentation SOAP format for PharmD students por Abel C. Mathew
Migraine case Presentation SOAP format for PharmD studentsMigraine case Presentation SOAP format for PharmD students
Migraine case Presentation SOAP format for PharmD students
Abel C. Mathew7.3K vistas
a case study on gastroenteritis por martinshaji
 a case study on gastroenteritis  a case study on gastroenteritis
a case study on gastroenteritis
martinshaji1.6K vistas
2 severe respiratory infections in the icu por Islam Ibrahim
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icu
Islam Ibrahim91 vistas
2 severe respiratory infections in the icu por Islam Ibrahim
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icu
Islam Ibrahim49 vistas
Duodenalulcer.pdf por JuniorDoc1
Duodenalulcer.pdfDuodenalulcer.pdf
Duodenalulcer.pdf
JuniorDoc12 vistas
Atrial fibrilitation with gea nuriza por soroylardo1
Atrial fibrilitation with gea nurizaAtrial fibrilitation with gea nuriza
Atrial fibrilitation with gea nuriza
soroylardo191 vistas
case report Mr J english day-2.pptx por ViviRosari1
case report Mr J english day-2.pptxcase report Mr J english day-2.pptx
case report Mr J english day-2.pptx
ViviRosari16 vistas
a case study on typhoid ( enteric fever) por martinshaji
a case study on typhoid ( enteric fever)a case study on typhoid ( enteric fever)
a case study on typhoid ( enteric fever)
martinshaji540 vistas
Case presentation on cholera by varam por surya720
Case presentation on cholera by varamCase presentation on cholera by varam
Case presentation on cholera by varam
surya7203.8K vistas
Case presentation Urosepsis por tbf413
Case presentation UrosepsisCase presentation Urosepsis
Case presentation Urosepsis
tbf41311.1K vistas

Más de ArunKumarP478781

walkathon viral hep.pptx por
walkathon viral hep.pptxwalkathon viral hep.pptx
walkathon viral hep.pptxArunKumarP478781
4 vistas6 diapositivas
suppositories.pptx por
suppositories.pptxsuppositories.pptx
suppositories.pptxArunKumarP478781
39 vistas47 diapositivas
kidney stones.pptx por
kidney stones.pptxkidney stones.pptx
kidney stones.pptxArunKumarP478781
5 vistas32 diapositivas
water and electrolytes.pptx por
water and electrolytes.pptxwater and electrolytes.pptx
water and electrolytes.pptxArunKumarP478781
4 vistas25 diapositivas
wound healing.pptx por
wound healing.pptxwound healing.pptx
wound healing.pptxArunKumarP478781
2 vistas7 diapositivas
Chronic kidney disease por
Chronic kidney disease Chronic kidney disease
Chronic kidney disease ArunKumarP478781
17 vistas11 diapositivas

Último

Depression PPT template por
Depression PPT templateDepression PPT template
Depression PPT templateEmanMegahed6
19 vistas36 diapositivas
Structural Racism and Public Health: How to Talk to Policymakers and Communit... por
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...katiequigley33
627 vistas31 diapositivas
sales forecasting (Pharma) por
sales forecasting (Pharma)sales forecasting (Pharma)
sales forecasting (Pharma)sristi51
8 vistas13 diapositivas
POWDERS.pptx por
POWDERS.pptxPOWDERS.pptx
POWDERS.pptxSUJITHA MARY
19 vistas42 diapositivas
LMLR 2023 Back and Joint Pain at 50 por
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50Allan Corpuz
324 vistas77 diapositivas
Complications & Solutions in Laparoscopic Hernia Surgery.pptx por
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptxVarunraju9
106 vistas21 diapositivas

Último(20)

Depression PPT template por EmanMegahed6
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed619 vistas
Structural Racism and Public Health: How to Talk to Policymakers and Communit... por katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley33627 vistas
sales forecasting (Pharma) por sristi51
sales forecasting (Pharma)sales forecasting (Pharma)
sales forecasting (Pharma)
sristi518 vistas
LMLR 2023 Back and Joint Pain at 50 por Allan Corpuz
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50
Allan Corpuz324 vistas
Complications & Solutions in Laparoscopic Hernia Surgery.pptx por Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9106 vistas
PATIENTCOUNSELLING in.pptx por skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi116 vistas
eTEP -RS Dr.TVR.pptx por Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9131 vistas
24th oct Pulp Therapy In Young Permanent Teeth.pptx por ismasajjad1
24th oct Pulp Therapy In Young Permanent Teeth.pptx24th oct Pulp Therapy In Young Permanent Teeth.pptx
24th oct Pulp Therapy In Young Permanent Teeth.pptx
ismasajjad18 vistas
Cholera Romy W. (3).pptx por rweth613
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61338 vistas
Referral-system_April-2023.pdf por manali9054
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905437 vistas
PCD Pharma Franchise In Chandigarh | Saphnix Lifesciences por Saphnix Lifesciences
PCD Pharma Franchise In Chandigarh | Saphnix LifesciencesPCD Pharma Franchise In Chandigarh | Saphnix Lifesciences
PCD Pharma Franchise In Chandigarh | Saphnix Lifesciences
STR-324.pdf por phbordeau
STR-324.pdfSTR-324.pdf
STR-324.pdf
phbordeau16 vistas
Lifestyle Measures to Prevent Brain Diseases.pptx por Sudhir Kumar
Lifestyle Measures to Prevent Brain Diseases.pptxLifestyle Measures to Prevent Brain Diseases.pptx
Lifestyle Measures to Prevent Brain Diseases.pptx
Sudhir Kumar623 vistas
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective por Golden Helix
VarSeq 2.5.0: VSClinical AMP Workflow from the User PerspectiveVarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
Golden Helix67 vistas
The relative risk of cancer from smoking and vaping nicotine por yfzsc5g7nm
The relative risk of cancer from smoking and vaping nicotine The relative risk of cancer from smoking and vaping nicotine
The relative risk of cancer from smoking and vaping nicotine
yfzsc5g7nm176 vistas

AIDS PATHOPHYSIOLOGY. pptx

  • 1. CASE STUDY ON PULMONARY TUBERCULOSIS PREPARED BY : D.LOGESHTHARAN PHARM.D 2ND YEAR (VISTAS)
  • 2. PATIENT DEMOGRAPHIC DETAILS • Patient Name : Mr. X • Age : 56 Years • Gender : Male • Date Of Admission : 14/01/2022 • Date Of Discharge : 19/01/2022 • Depart : Chest & TB
  • 3. CHIEF COMPLAINTS A 56 Years Old Male Patient Came To The Hospital With The Complaints Of  Cough with Expectoration Which is Whitish in Color Since 2 Months Tiredness
  • 4. HISTORY OF PRESENT ILLNESS Patient was apparently normal 2 months ago when he developed cough with expectoration which is whitish in color which is not foul smelling.  H/O fatigue, lethargy, weight loss of about 6 Kg and fever. PAST MEDICAL HISTORY : NIL PAST MEDICATION HISTORY : NIL
  • 5. PERSONAL HISTORY / SOCIAL HABITS Normal bowel and bladder habits SMOKER : YES ALCOHOLIC : YES
  • 6. OBJECTIVE EVIDENCE • The Patient Is Conscious • Febrile • Temp : 100 • Pulse : 78 Beats/Min • BP : 120/80mm Hg • CVS :S1s2+ve • RS : Crepts • CNS : NFND • P/A : Soft PHYSICAL EXAMINATION SYSTEM EXAMINATION
  • 7. LABORATORY INVESTIGATIONS PARAMETER OBSERVED VALUE NORMAL VALUE HAEMOGLOBIN 13.5g / dl 14 – 18 g/dl TC 39000/mm³ 32000-98000/mm³ ESR 40 mm in 1st hour 0-30 mm in 1st hour PACKED CELL VOLUME ( PCV) 39.3% 33-43 % MCV 79 µm³ 76-100ͯµm³ RBC 4.9 millions/cu mm 3.6 – 5 millions/cu mm TOTAL WBC 6,400 cells/cu mm 4500 – 11000 per µl PLATELET COUNT 3.02 l/cmm 1.4 – 4.5 l/cmm BICARBONATE 27mmol/L Below 3.0mg/dl ELECTROLYTE PROFILE
  • 8. LABORATORY INVESTIGATIONS PARAMETER OBSERVED VALUE NORMAL VALUE LIVER Bili (T) 0.9 mg/dl (< 1.0) Bili (D) 0.2 mg/dl (< 0.2) Bili (ID) 0.2 mg/dl (< 0.8) SGPT 9 U/L (Upto 35) SGOT 17 U/L (Upto 40) T.Protein 7.19 g% (6.0 – 8.0) Alk. Phosphatase 115 U/L (40 – 130) Albumin 3.7 g% (3.2 – 4.5) Glubulin 3.4 g% (2.3 – 3.5)
  • 9. OTHER TESTS : • Chest XRAY • Sputum AFB IMPRESSION : • Chest XRAY – Significant Cavites Found • Sputum AFB : A+ , B+ DIAGNOSIS : • PULMONARY TUBERCULOSIS
  • 10. ASSESSMENT • From The Subjective And Objective Evidence The Patient Is Assessed To Have PULMONARY TUBERCULOSIS
  • 11. TREATMENT S.N O BRAND NAME GENERIC NAME DOSE FREQUENCY 1D 2D 3D 1 Inj.Ceftrioxone Ciprofloxacin 500 mg 1-0-1    2 Inj.Amikacin Amikin 250 mg 1-1-1    3 T.Para Sulfasalazine 500 mg 1-1-1    4 T.AKT 4 Isoniazid, Riampicin , Pyrazenamid 2I,R1 Z,E 1-0-1   
  • 12. DRUGS ON DISCHARGE S.N O BRAND NAME GENERIC NAME DOSE FREQUENCY 1D 2D 3D 1 Inj.Ceftrioxone Ciprofloxacin 500 mg 1-0-1    2 Inj.Amikacin Amikin 250 mg 1-1-1    3 T.Para Sulfasalazine 500 mg 1-1-1    4 T.AKT 4 Isoniazid, Riampicin , Pyrazenamid 2I,R1 Z,E 1-0-1   
  • 13. DRUG INTERACTION : Amikacin can sometimes cause kidney damage, and using it with a cephalosporin antibiotic like ceftriaxone may increase that risk. Signs and symptoms of kidney damage may include nausea , vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. cefTRIAXone = amikacin Applies to: ceftriaxone, Amikin (amikacin) PHARMACIST INTERVENTION
  • 14. SUBJECTIVE A 56 years old male patient was admitted in the hospital with c/o cough with expectoration which is whitish in color since2 months H/O fatigue, lethargy, weight loss of about 6 kg and fever. Personal history: He is a smoker and alcoholic. OBJECTIVE Systemic and physical examination was found to be normal SGPT and GOT were found to be Decreased. Chest X ray: Significant cavities found Sputum AFB: A+ B+ ASSESSMENT PULMONARY TUBERCULOSIS PLAN OF TREATMENT Patient was given treatment with T.Para Inj.Ceftrioxone, T.AKT 4,Inj. Amikacin. SOAP NOTES
  • 15.  T.Para (Paracetamol): It is an analgesic and antipyretic drug used to relieve from fever andpain. Take one tablet whenever required  Inj.Ceftrioxone: It is an antibiotic used to treat any infections. It is given twice daily.  T.AKT 4:(Isoniazid + Rifampicin + Pyrazenamide): These drugs are given to treat active tuberculosis infection. Take 2tablet of each thrice weekly  Inj. Amikacin: It is an antibiotic. This injection is given twice in a week
  • 16. PATIENT COUNSELLING • REGARDING DISEASE CONDITION:  Cover your mouth and nose with a tissue.  Put your used tissue in a closed bag and throw it away.  If you don't have a tissue, cough or sneeze into your upper sleeve or elbow, not your hands.  Wash your hands often with soap and warm water for 20 seconds.
  • 17. • REGARDING DRUGS: Avoid Dairy Products Such As Milk,cheese,ice Cream While Taking INJ.AMIKACIN TO FACILITATE DRUG ABSORPTION IN THE EMPTY STOMACH, YOU ARE ADVISED NOT TO TAKE FOOD FOR 2 HOURS BEFORE AND AFTER TAKING DRUGS. Quit Alcohol When Taking Medications
  • 18. • REGARDING THERAPEUTIC LIFESTYLE MODIFICATIONS: As a TB patient, you must avoid caffeine, refined sugar and flour, sodium, and bottled sauces.  Foods containing saturated and trans fats worsen the TB symptoms of diarrhoea and abdominal cramping and fatigue.  Additionally, alcohol and tobacco are a definite no-no during the disease treatment and cure phase